Upcoming presentations on emerging wet AMD treatment strategies, including TKI, gene therapy, and personalized anti-VEGF therapy. Medscape
Category: News
AAO 2026 Preview: Emerging Therapies for Wet AMD
Anticipated presentations on emerging wet AMD treatment strategies, including TKI, gene therapy, and individualized anti-VEGF therapy. Medscape
EURETINA 2026
Read clinically focused news coverage of key developments from EURETINA 2026. Medscape Ophthalmology
New Global Survey by Johnson & Johnson Finds Most Women Don’t Connect Eye Health Changes with Menopause
JACKSONVILLE, Fla.–(BUSINESS WIRE)–New global survey by Johnson & Johnson finds most women don’t connect eye health changes with menopause
Extraintestinal Manifestations of UC: 5 Things to Know
Experts share practical guidance on recognizing extraintestinal manifestations and coordinating care for patients with ulcerative colitis. Medscape Gastroenterology
Ray Therapeutics Awarded $8 Million CIRM Grant to Advance RTx-021 Gene Therapy for Stargardt Disease
BERKELEY, Calif.–(BUSINESS WIRE)–Ray Therapeutics (RayTx), an industry-leading clinical-stage biopharmaceutical company pioneering differentiated vision restoration therapies for those living with severe retinal degenerations, today announced it has …
Erectile Dysfunction Pills and Diabetic Eyes: A Link?
Among men aged 50 years or older with diabetes and erectile dysfunction, the use of erectile dysfunction drugs was associated with a lower rate of developing proliferative diabetic retinopathy. Medscape Medical News
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
OBIO’s Capital Access Advisory Program (CAAP®) Reaches Milestone with $1 Billion Raised by High-Growth Life Sciences and Health Tech Ventures
TORONTO–(BUSINESS WIRE)–OBIO® companies supported through its Capital Access Advisory Program have now collectively raised over $1 billion in capital.
Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap to Treat Dry Eye Disease
CONCORD, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced intent to submit to the…
Rapid Dry Eye Relief With Investigational Reproxalap Drop
An investigational eye drop relieves symptoms of dry eye disease as early as week 1 in a pooled analysis of two trials, with mild irritation at the drop site being the most common side effect. Medscape Medical News
EyeCare Partners Announces Sale of Optometry Business
ST. LOUIS–(BUSINESS WIRE)–EyeCare Partners LLC (“EyeCare Partners” or the “Company”), the nation’s leading provider of clinically integrated eye care, announced today that it has entered into an agreement for the sale of its optometry business to MyE…
MyEyeDr. To Acquire EyeCare Partners Optometry Division
VIENNA, Va.–(BUSINESS WIRE)–MyEyeDr., a leading provider of comprehensive eye care and eyewear solutions, announced today that it has entered into an agreement with EyeCare Partners to acquire its optometry division, consisting of over 300 offices, i…
Age Affects Dupilumab’s Quality-of-Life Benefits in Kids
Dupilumab appears to improve young children’s eczema, but they experience more itching and skin irritation than older children and teens. Medscape Medical News
Verbraucherumfrage von STAAR Surgical: 71 Prozent der Deutschen möchten auf Sehhilfen verzichten, kennen aber ihre Alternativen nicht
HAMBURG, Germany–(BUSINESS WIRE)–Die STAAR Surgical Company, weltweit führender Anbieter von phakischen Intraokularlinsen mit der EVO™-Produktfamilie implantierbarer Collamer®-Linsen (EVO ICL™) zur Sehkorrektur, hat die Ergebnisse ihrer globalen Verb…
PCV: Retina Scans May Guide Who Needs Ongoing Eye Injections
For patients with polypoidal choroidal vasculopathy, complete regression with aflibercept does not ensure lasting remission, but posttreatment OCT findings may help predict who will have a recurrence. Medscape Medical News
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors, at a regul…
STAAR Surgical Board Approves $50 Million Share Repurchase Authorization
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO™ family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that its Board of Directors, at a regul…
Medscape Poll: AI in Ophthalmology — The Road Ahead
From the approval in 2018 of the IDx-DR to today, eye care is one of the areas of medicine in which AI is making the biggest early impact. Medscape Reader Polls
Ora Launches Clinical Intelligence Committee, Bringing Collective KOL Guidance to Ophthalmic Research
BOSTON–(BUSINESS WIRE)– #clinicalresearch–Ophthalmic CRO Ora launches Clinical Intelligence Committee, expert network helps innovators navigate complexity, bring therapies to patients faster